avapro has been researched along with Alveolitis, Fibrosing in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsayed, HA | 1 |
| Mohammad, HMF | 1 |
| Khalil, CM | 1 |
| El-Kherbetawy, MK | 1 |
| Elaidy, SM | 1 |
| Marut, W | 1 |
| Kavian, N | 1 |
| Servettaz, A | 1 |
| Hua-Huy, T | 1 |
| Nicco, C | 1 |
| Chéreau, C | 1 |
| Weill, B | 1 |
| Dinh-Xuan, AT | 1 |
| Batteux, F | 1 |
2 other studies available for avapro and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin.
Topics: Animals; Autophagy; Bleomycin; Epithelial-Mesenchymal Transition; Irbesartan; Mammals; Pulmonary Fib | 2022 |
Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Biphenyl Compoun | 2013 |